Oncocyte Target Price

Explore Oncocyte's target price with historical charts and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Share Price

$3.2

Average Target Price

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

Date	Analyst	Price Target	Current Upside/Downside
2025-05-21	UBSThomas Flaten	$8	150% upside
2024-04-24	NeedhamMike Matson	$4.25	32.8% upside
2022-12-01	Lake Street	$10	212.5% upside
2022-11-18	Piper Sandler	$10	212.5% upside
2022-08-17	Piper SandlerDavid Westenberg	$30	837.5% upside
2022-08-11	Lake Street	$60	1775% upside
2022-08-11	Needham	$42	1212.5% upside
2022-05-15	Piper SandlerDavid Westenberg	$28	775% upside

Oncocyte (OCX) FAQ

Stockcircle tracks target price for Oncocyte (OCX), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Target Price page is built for Oncocyte's historical target price trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use target price as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main OCX overview so you can move from this figure to the surrounding analysis quickly.